Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas - PubMed (original) (raw)
. 2001 May 15;61(10):3932-6.
Affiliations
- PMID: 11358808
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas
K Schumacher et al. Cancer Res. 2001.
Abstract
The purpose of this study was to explore whether there is a linkage between the infiltration of CD8(+) T cells and the risk of death from esophageal cancer. Cases of 70 consecutive patients in whom esophageal squamous cell carcinomas ( n = 33) or adenocarcinomas (n = 37) were R0-resected between 1993 and 1999 were reviewed. The presence of activated CD8(+) T cells was evaluated by quantitative real-time PCR and immunohistochemistry and compared to clinical and pathological stages. The primary end point analyzed was overall survival, and a multivariate analysis was performed to distinguish any factors conferring an improved survivorship. Intratumoral (i.t.) CD8(+) T cells accumulating within the epithelial complexes were detected in 11 of all (16%) cases: in 9 of 25 (36%) patients with Union Internationale Contrele Cancer stage I or II versus 2 of 45 (4%) patients with Union Internationale Contrele Cancer stage III or IV (P = 0.001). Intratumoral CD8(+) T cell infiltrations showed proliferative activity and also IFN-gamma secretion. The presence of i.t. CD8(+) T cell infiltration more than peritumoral infiltration was associated with a good prognosis in both squamous cell and adenocarcinomas. Multivariate analysis showed that i.t. CD8(+) T cell infiltration was an independent prognostic factor (hazard ratio, 0.5; P = 0.0004) indicating favorable outcome. In conclusion, the presence of CD8(+) T cell infiltration in esophageal carcinomas is a favorable prognostic factor that should have diagnostic and therapeutic implications.
Similar articles
- Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O, Ishii G, Kubota K, Murata Y, Naito Y, Mizuno T, Aokage K, Saijo N, Nishiwaki Y, Gemma A, Kudoh S, Ochiai A. Kawai O, et al. Cancer. 2008 Sep 15;113(6):1387-95. doi: 10.1002/cncr.23712. Cancer. 2008. PMID: 18671239 - CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma.
Cho Y, Miyamoto M, Kato K, Fukunaga A, Shichinohe T, Kawarada Y, Hida Y, Oshikiri T, Kurokawa T, Suzuoki M, Nakakubo Y, Hiraoka K, Murakami S, Shinohara T, Itoh T, Okushiba S, Kondo S, Katoh H. Cho Y, et al. Cancer Res. 2003 Apr 1;63(7):1555-9. Cancer Res. 2003. PMID: 12670904 - Prognostic significance of intratumoral natural killer cells in primary resected esophageal squamous cell carcinoma.
Hsia JY, Chen JT, Chen CY, Hsu CP, Miaw J, Huang YS, Yang CY. Hsia JY, et al. Chang Gung Med J. 2005 May;28(5):335-40. Chang Gung Med J. 2005. PMID: 16086548 - Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Mariette C, et al. Ann Thorac Surg. 2004 Oct;78(4):1177-83. doi: 10.1016/j.athoracsur.2004.02.068. Ann Thorac Surg. 2004. PMID: 15464466 Review. - Prognostic and predictive impact of intra- and peritumoral immune infiltrates.
Fridman WH, Galon J, Pagès F, Tartour E, Sautès-Fridman C, Kroemer G. Fridman WH, et al. Cancer Res. 2011 Sep 1;71(17):5601-5. doi: 10.1158/0008-5472.CAN-11-1316. Epub 2011 Aug 16. Cancer Res. 2011. PMID: 21846822 Review.
Cited by
- Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors.
Albershardt TC, Leleux J, Parsons AJ, Krull JE, Berglund P, Ter Meulen J. Albershardt TC, et al. NPJ Vaccines. 2020 Jun 16;5(1):50. doi: 10.1038/s41541-020-0201-x. eCollection 2020. NPJ Vaccines. 2020. PMID: 32579133 Free PMC article. - The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy.
Lança T, Silva-Santos B. Lança T, et al. Oncoimmunology. 2012 Aug 1;1(5):717-725. doi: 10.4161/onci.20068. Oncoimmunology. 2012. PMID: 22934263 Free PMC article. - Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
Chen K, Cheng G, Zhang F, Zhang N, Li D, Jin J, Wu J, Ying L, Mao W, Su D. Chen K, et al. Oncotarget. 2016 May 24;7(21):30772-80. doi: 10.18632/oncotarget.8956. Oncotarget. 2016. PMID: 27120796 Free PMC article. - Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.
Serafini P, Meckel K, Kelso M, Noonan K, Califano J, Koch W, Dolcetti L, Bronte V, Borrello I. Serafini P, et al. J Exp Med. 2006 Nov 27;203(12):2691-702. doi: 10.1084/jem.20061104. Epub 2006 Nov 13. J Exp Med. 2006. PMID: 17101732 Free PMC article. - Potential functional role of plasmacytoid dendritic cells in cancer immunity.
Kim R, Emi M, Tanabe K, Arihiro K. Kim R, et al. Immunology. 2007 Jun;121(2):149-57. doi: 10.1111/j.1365-2567.2007.02579.x. Epub 2007 Mar 20. Immunology. 2007. PMID: 17371541 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials